Multiple resections for patients with glioblastoma: prolonging survival

Clinical article

View More View Less
  • 1 Departments of Neurosurgery and
  • 2 Neuro-Oncology, Neuro-Oncology Outcomes Laboratory, Johns Hopkins University, Baltimore, Maryland
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

Glioblastoma is the most common and aggressive type of primary brain tumor in adults. These tumors recur regardless of intervention. This propensity to recur despite aggressive therapies has made many perceive that repeated resections have little utility. The goal of this study was to evaluate if patients who underwent repeat resections experienced improved survival as compared with patients with fewer numbers of resections, and whether the number of resections was an independent predictor of prolonged survival.

Methods

The records of adult patients who underwent surgery for an intracranial primary glioblastoma at an academic tertiary-care institution between 1997 and 2007 were retrospectively reviewed. Multivariate proportionalhazards regression analysis was used to identify an association between glioblastoma resection number and survival after controlling for factors known to be associated with survival, such as age, functional status, periventricular location, extent of resection, and adjuvant therapy. Survival as a function of time was plotted using the Kaplan-Meier method, and survival rates were compared using log-rank analysis.

Results

Five hundred seventy-eight patients with primary glioblastoma met the inclusion/exclusion criteria. At last follow-up, 354, 168, 41, and 15 patients underwent 1, 2, 3, or 4 resections, respectively. The median survival for patients who underwent 1, 2, 3, and 4 resections was 6.8, 15.5, 22.4, and 26.6 months (p < 0.05), respectively. In multivariate analysis, patients who underwent only 1 resection experienced shortened survival (relative risk [RR] 3.400, 95% CI 2.423–4.774; p < 0.0001) as compared with patients who underwent 2 (RR 0.688, 95% CI 0.525–0.898; p = 0.0006), 3 (RR 0.614, 95% CI 0.388–0.929; p = 0.02), or 4 (RR 0.600, 95% CI 0.238–0.853; p = 0.01) resections. These results were verified in a case-control evaluation, controlling for age, neurological function, periventricular tumor location, extent of resection, and adjuvant therapy. Patients who underwent 1, 2, or 3 resections had a median survival of 4.5, 16.2, and 24.4 months, respectively (p < 0.05). Additionally, the risk of infections or iatrogenic deficits did not increase with repeated resections in this patient population (p > 0.05).

Conclusions

Patients with glioblastoma will inevitably experience tumor recurrence. The present study shows that patients with recurrent glioblastoma can have improved survival with repeated resections. The findings of this study, however, may be limited by an intrinsic bias associated with patient selection. The authors attempted to minimize these biases by using strict inclusion criteria, multivariate analyses, and case-control evaluation.

Abbreviations used in this paper:GTR = gross-total resection; IQR = interquartile range; KPS = Karnofsky Performance Scale; RR = relative risk; STR = subtotal resection.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Kaisorn L. Chaichana, M.D., The Johns Hopkins Hospital, Department of Neurosurgery, Johns Hopkins University, 600 North Wolfe Street, Meyer 8-184, Baltimore, Maryland 21202. email: kaisorn@jhmi.edu.

Please include this information when citing this paper: published online October 19, 2012; DOI: 10.3171/2012.9.JNS1277.

  • 1

    Azizi A, , Black P, , Miyamoto C, & Croul SE: Treatment of malignant astrocytomas with repetitive resections: a longitudinal study. Isr Med Assoc J 3:254257, 2001

    • Search Google Scholar
    • Export Citation
  • 2

    Barker FG II, , Chang SM, , Gutin PH, , Malec MK, , McDermott MW, & Prados MD, : Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709723, 1998

    • Search Google Scholar
    • Export Citation
  • 3

    Brem H, , Piantadosi S, , Burger PC, , Walker M, , Selker R, & Vick NA, : Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:10081012, 1995

    • Search Google Scholar
    • Export Citation
  • 4

    Chaichana K, , Parker S, , Olivi A, & Quiñones-Hinojosa A: A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. Clinical article. J Neurosurg 112:9971004, 2010

    • Search Google Scholar
    • Export Citation
  • 5

    Chaichana KL, , Chaichana KK, , Olivi A, , Weingart JD, , Bennett R, & Brem H, : Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg 114:587594, 2011

    • Search Google Scholar
    • Export Citation
  • 6

    Chaichana KL, , Garzon-Muvdi T, , Parker S, , Weingart JD, , Olivi A, & Bennett R, : Supratentorial glioblastoma multiforme: the role of surgical resection versus biopsy among older patients. Ann Surg Oncol 18:239245, 2011

    • Search Google Scholar
    • Export Citation
  • 7

    Chaichana KL, , Halthore AN, , Parker SL, , Olivi A, , Weingart JD, & Brem H, : Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. J Neurosurg 114:604612, 2011

    • Search Google Scholar
    • Export Citation
  • 8

    Chaichana KL, , McGirt MJ, , Frazier J, , Attenello F, , Guerrero-Cazares H, & Quinones-Hinojosa A: Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 89:219224, 2008

    • Search Google Scholar
    • Export Citation
  • 9

    Chaichana KL, , Zaidi H, , Pendleton C, , McGirt MJ, , Grossman R, & Weingart JD, : The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival. Neurol Res 33:759764, 2011

    • Search Google Scholar
    • Export Citation
  • 10

    Dandy WE: Removal of right cerebral hemisphere for certain tumors with hemiplegia. JAMA 90:823825, 1928

  • 11

    DeAngelis LM: Brain tumors. N Engl J Med 344:114123, 2001

  • 12

    Dutta D, , Vanere P, , Gupta T, , Munshi A, & Jalali R: Factors influencing activities of daily living using FIM-FAM scoring system before starting adjuvant treatment in patients with brain tumors: results from a prospective study. J Neurooncol 94:103110, 2009

    • Search Google Scholar
    • Export Citation
  • 13

    Gallia GL, , Brem S, & Brem H: Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl Compr Canc Netw 3:721728, 2005

    • Search Google Scholar
    • Export Citation
  • 14

    Genc M, , Zorlu AF, & Atahan IL: Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas. Radiother Oncol 56:233238, 2000

    • Search Google Scholar
    • Export Citation
  • 15

    Harsh GR IV, , Levin VA, , Gutin PH, , Seager M, , Silver P, & Wilson CB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615621, 1987

    • Search Google Scholar
    • Export Citation
  • 16

    Hart MG, , Grant R, , Garside R, , Rogers G, , Somerville M, & Stein K: Temozolomide for high grade glioma. Cochrane Database Syst Rev 4:CD007415, 2008

    • Search Google Scholar
    • Export Citation
  • 17

    Hau P, , Baumgart U, , Pfeifer K, , Bock A, , Jauch T, & Dietrich J, : Salvage therapy in patients with glioblastoma: is there any benefit?. Cancer 98:26782686, 2003

    • Search Google Scholar
    • Export Citation
  • 18

    Hegi ME, , Diserens AC, , Gorlia T, , Hamou MF, , de Tribolet N, & Weller M, : MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:9971003, 2005

    • Search Google Scholar
    • Export Citation
  • 19

    Helseth R, , Helseth E, , Johannesen TB, , Langberg CW, , Lote K, & Rønning P, : Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122:159167, 2010

    • Search Google Scholar
    • Export Citation
  • 20

    Keles GE, , Anderson B, & Berger MS: The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371379, 1999

    • Search Google Scholar
    • Export Citation
  • 21

    Kleihues P, , Louis DN, , Scheithauer BW, , Rorke LB, , Reifenberger G, & Burger PC, : The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215229, 2002

    • Search Google Scholar
    • Export Citation
  • 22

    Lacroix M, , Abi-Said D, , Fourney DR, , Gokaslan ZL, , Shi W, & DeMonte F, : A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190198, 2001

    • Search Google Scholar
    • Export Citation
  • 23

    Lamborn KR, , Chang SM, & Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227235, 2004

    • Search Google Scholar
    • Export Citation
  • 24

    Louis DN, , Ohgaki H, , Wiestler OD, , Cavenee WK, , Burger PC, & Jouvet A, : The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97109, 2007

    • Search Google Scholar
    • Export Citation
  • 25

    McGirt MJ, , Chaichana KL, , Gathinji M, , Attenello FJ, , Than K, & Olivi A, : Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156162, 2009

    • Search Google Scholar
    • Export Citation
  • 26

    McGirt MJ, , Mukherjee D, , Chaichana KL, , Than KD, , Weingart JD, & Quinones-Hinojosa A: Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463470, 2009

    • Search Google Scholar
    • Export Citation
  • 27

    McGirt MJ, , Than KD, , Weingart JD, , Chaichana KL, , Attenello FJ, & Olivi A, : Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. Clinical article. J Neurosurg 110:583588, 2009

    • Search Google Scholar
    • Export Citation
  • 28

    Nieder C, , Grosu AL, & Molls M: A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 26:397409, 2000

  • 29

    Parsons DW, , Jones S, , Zhang X, , Lin JC, , Leary RJ, & Angenendt P, : An integrated genomic analysis of human glioblastoma multiforme. Science 321:18071812, 2008

    • Search Google Scholar
    • Export Citation
  • 30

    Quiñones-Hinojosa A, & Chaichana K: The human subventricular zone: a source of new cells and a potential source of brain tumors. Exp Neurol 205:313324, 2007

    • Search Google Scholar
    • Export Citation
  • 31

    Sanai N, , Polley MY, , McDermott MW, , Parsa AT, & Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. Clinical article. J Neurosurg 115:38, 2011

    • Search Google Scholar
    • Export Citation
  • 32

    Sathornsumetee S, & Rich JN: New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 6:10871104, 2006

  • 33

    Stark AM, , Nabavi A, , Mehdorn HM, & Blömer U: Glioblastoma multiforme—report of 267 cases treated at a single institution. Surg Neurol 63:162169, 2005

    • Search Google Scholar
    • Export Citation
  • 34

    Stupp R, , Mason WP, , van den Bent MJ, , Weller M, , Fisher B, & Taphoorn MJ, : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987996, 2005

    • Search Google Scholar
    • Export Citation
  • 35

    Subach BR, , Witham TF, , Kondziolka D, , Lunsford LD, , Bozik M, & Schiff D: Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery 45:1723, 1999

    • Search Google Scholar
    • Export Citation
  • 36

    Westphal M, , Ram Z, , Riddle V, , Hilt D, & Bortey E: Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148:269275, 2006

    • Search Google Scholar
    • Export Citation
  • 37

    Wong ET, , Hess KR, , Gleason MJ, , Jaeckle KA, , Kyritsis AP, & Prados MD, : Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17:2572578, 1999

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 613 277 24
Full Text Views 361 67 3
PDF Downloads 195 36 1
EPUB Downloads 0 0 0